Objective: To assess vitamin B6 intake and status of critically ill patients. The relationship between vitamin B6 status indicators and the severity of illness and outcome in these patients was also examined. Design: Prospective clinical study. Setting: The study was performed at the Taichung Veteran General Hospital, in the central part of Taiwan. Subjects: Ninety-four patients in the intensive care unit (ICU) entered the study and 46 patients successfully completed this study. Interventions: No intervention. Main outcome measures: Vitamin B6 intake was recorded for 14 days. Vitamin B6 status was assessed by direct measures (plasma pyridoxal 5 0 -phosphate (PLP), pyridoxal (PL), and urinary 4-pyridoxic acid (4-PA)) and indirect measures (erythrocyte alanine (EALT-AC) and aspartate (EAST-AC) aminotransaminase activity coefficient). The severity of illness (APACHE II score), the length of ventilation dependency, and the length of ICU and hospital stay were recorded. Results: Patients had an adequate mean vitamin B6 intake (16.26 AE 19.39 mg) during the 14 day study. Mean vitamin B6 intake was significantly higher on day 14 than on day 1 (P < 0.001). However, plasma PLP and PL concentrations significantly decreased at the 14th day after admission (P < 0.05). Erythrocyte alanine aminotransaminase activity coefficient and EAST-AC did not change significantly. Urinary 4-PA significantly increased at the 14th day (P < 0.001). No significant relationships were found between APACHE II scores and clinical outcomes (the length of ICU and hospital stay, the length of ventilation dependency) of patients, vitamin B6 intake or status indicators. Conclusions: Critically ill patients received nutritional support in the ICU, and had sufficient mean vitamin B6 intake and adequate vitamin B6 status. Therefore, the severity of illness and the results should not be affected by vitamin B6 status. However, we have noted that plasma PLP and PL concentrations significantly decreased while vitamin B6 intake significantly increased on day 14. Critical clinical conditions and complex metabolism in the critically ill may account for the reduction of plasma PLP and PL. Since vitamin B6 deficiency causes profound effects on immune system function, dietary or supplemented vitamin B6 intake is suggested for hospitalized patients.
Introduction
Several studies (Potera et al, 1977; Vir & Love, 1978; Louw et al, 1992; Pfitzenmeyer et al, 1997) have reported lower vitamin B6 status in hospitalized patients. Potera et al (1977) reported that advanced breast cancer patients had significantly lower plasma PLP levels than healthy women of similar age. Vir and Love (1978) investigated vitamin B6 status in 102 hospitalized aged people. There was a high prevalence of lower vitamin B6 status in both aged male and female subjects. They (Vir & Love, 1978) suggested that a diet higher in vitamin B6 should be given to aged patients. Louw et al (1992) found PLP decreased to values below the respective normal range during the acute-phase response. However, little is known about the intake and nutritional status of vitamin B6 in critically ill patients who have more complicated clinical conditions.
The physiological active coenzyme form of vitamin B6, PLP, is required for normal nucleic acid and protein synthesis and for cellular multiplication. Isolated vitamin B6 deficiencies cause more profound effects on immune system functions than deficiencies of any other B group vitamins (Leklem, 1988) . Thus, in critically ill patients, having a lower vitamin B6 status may depress immune responses. Pyridoxal 5 0 -phosphate and PL are both bound to serum albumin while being transported by the blood. The binding of PLP and PL to serum albumin in the circulation serves to protect it from hydrolysis and allows for the delivery of PLP and PL to other tissues. Critically ill patients often have a compromised protein status (Bassili & Deitel, 1981; Larca & Greenbaum, 1982; Christman & McCain, 1993; Huang et al, 2000) . The question has been raised whether vitamin B6 status is affected in these patients. The purpose of this study was to assess vitamin B6 intake and vitamin B6 status of critically ill patients by using direct measures (plasma PLP and PL, and urinary 4-PA) and indirect measures (EALT-AC and EAST-AC). In addition, the relationship between vitamin B6 status parameters, the severity of illness (Acute Physiology and Chronic Health Evaluation; APACHE II score) and clinical outcomes (the length of ICU and hospital stay, the length of ventilation dependency) in these patients was also examined.
Methods

Patients
This study was conducted at the Taichung Veteran General Hospital, which is a 1359-bed teaching hospital in the central part of Taiwan. All patients admitted or transferred to the ICU were screened for potential study participation. Only patients completing the study and requiring at least 14 days of mechanical ventilation were included. Patients were excluded if they were clinically unstable or unconscious during the study. Ninety-four patients entered the study, however only 46 patients (36 males, 10 females) successfully completed this study. All patients received nutritional support either enteral nutrition (EN; n ¼ 12), total parenteral nutrition (TPN; n ¼ 16) or combined (EN plus TPN; n ¼ 18) based on the physician's recommendations. Patients received an enteral feed via a nasogastric tube. The composition of tube feeding formula was prepared from various commercial formula based on the patient's nutritional needs. The TPN regimen was given as a continuous infusion via a superior venacaval vein. The parenteral feed contained glutamine-free crystalline L-amino acids, carbohydrate in the form of 25% dextrose, 10 or 20% fat emulsion (1.1 kcal=ml or 2 kcal=ml), vitamins and minerals. Additional multivitamin supplements (containing 15 mg vitamin B6) were also given to the patients based on the physician's decision. Daily macronutrients (carbohydrate, lipid and protein) and vitamin B6 intakes from EN, TPN and intravenous crystalloid infusions were recorded routinely by the ICU nurses and dietitians. Medical records including diagnosis, the APACHE II score, length of ICU stay and of hospital stay, and ventilatory dependency were obtained. Patient's age, sex, height, weight and severity of illness on admission were assessed within 24 h of admission and again after 2 weeks in the ICU. The body mass index (BMI; kg=m 2 ) was calculated. The severity of illness was evaluated by the ACPACHE II score (Knaus et al, 1985) . Informed consent for participation was obtained. The study was approved by the Committee for Ethics of Chung Shan Medical and Dental College.
Biochemical measurements
Fasting venous blood samples were collected to estimate hematological (ie complete blood count, total lymphocyte count (TLC), serum albumin, and hemoglobin) and vitamin B6 status on the 1st and 14th day in the ICU. Plasma and red blood cells were separated and stored frozen (720 C) until analysis. Plasma and erythrocytes were prepared as previously described (Woodring & Storvick, 1970) .
Plasma PLP and PL were determined by high performance liquid chromatography (HPLC) as previously described (Edwards et al, 1989) . The fluorescence detector excitation and emission wavelengths were 300 and 400 nm, respectively. Plasma PLP and PL concentrations were identified and quantified by comparing retention times and peak areas with standards. Erythrocyte alanine aminotransferase and erythrocyte EAST with and without PLP stimulation in vitro were measured by the method of Woodring and Storvick (1970) . The interassay variabilities of plasma PLP, PL, EALT-AC and EAST-AC were 11.7% (n ¼ 20), 11.9% (n ¼ 20), 5.0% (n ¼ 10) and 2.1% (n ¼ 18), respectively. Plasma B6 concentrations and transaminase activity measurements were carried out under yellow light to prevent photodestruction.
Twenty-four-hour urine collections were obtained on the 1st and 14th day in the ICU. The pH of the urine samples was maintained at $ 3.0 by the addition of 1 N HCl. Twenty-fourhour urine volumes were determined and aliquots stored frozen (720 C) until analysis. Urinary 4-PA was analyzed by HPLC by the modified method of Gregory and Kirk (1979) . Initial addition of trichloroacetic acid (TCA) to the urine was omitted in order to avoid formation of the 4-PA lactone. Instead the urine samples were centrifuged at 3000 g for 10 min to remove particulate material and syringe filtered (0.45 mm; Nalge Co., Rochester, NY). Urine was then injected directly onto the HPLC column. All urine samples thawed for 4-PA determination were kept on ice to prevent lactonization of 4-PA. Creatinine concentrations were determined in all urine samples using a colorimetric kit (Sigma Chemical Co., St Louis, MO). 
Results
Characteristics of all patients are shown in Table 1 . Patients' ages ranged from 23 to 85 y. Mean current weight and BMI did not significantly change between the 1st and the 14th day after admission. There were no significant changes for APACHE II score comparing day 1 with day 14. The mean duration of time on the ventilator during hospital stay was 56 days with a range of 17 -193 days. The mean duration of stay in the ICU was 39 days (range 17 -98 days) and in the hospital was 75 day (range 21 -346 days) for all patients. No patients died during the study. The diagnosis of patients at the time of admission to the ICU is listed in Table 2 . The most common diagnoses were gastrointestinal disorders and malignant neoplasms.
Dietary intakes
Energy, protein, vitamin B6, and the ratio of vitamin B6 to protein (mg=g) on the 1st and 14th day after admission to the ICU are listed in Table 3 . Patients had significantly higher energy (P < 0.01) and vitamin B6 (P < 0.001) intakes, and the ratio of vitamin B6 to protein (mg=g; P < 0.01) on the 1st than on the 14th day after admission to the ICU. The mean vitamin B6 intake on the 1st and 14th days was higher than the US Dietary Reference Intakes (Food and Nutrition Board, Institute of Medicine, 1998; 1.7 mg=day for elderly men and 1.5 mg=day for elderly women) and the current Taiwan Recommended Daily Nutrient Allowance (Department of Health, Taiwan, 1993) of 1.6 mg=day for elderly men and 1.4 mg=day for elderly women. Although many patients have adequate vitamin B6 intake, individual variation was also considered. Individual vitamin B6 intake ranged from 0 to 87.8 mg on the 1st day and 0 to 86.5 mg on the 14th day.
Vitamin B6 status Biochemical indicators of vitamin B6 status on 1st and 14th day after admission to the ICU are shown in Table 4 . Although patients had a mean plasma PLP concentration higher than a cutoff of 20 nmol=l (Food and Nutrition Board Institute of Medicine, 1998; Lui et al, 1985) , mean plasma PLP and PL concentrations significantly (P < 0.05) decreased on the 14th day when compared with the value on the 1st day. We did not find that vitamin B6 or protein intake affected plasma PLP or PL concentrations. The mean EALT-AC and EAST-AC values did not significantly change between the 1st and 14th day in the ICU (Table 4 ). The mean EALT-AC was < 1.25 on the 14th day, the suggested value for adequate vitamin B6 status (Leklem, 1990) . The mean EAST-AC value of patients was also lower than the suggested value ( < 1.8) for adequate vitamin B6 status (Leklem, 1990 ). Dietary energy, protein or vitamin B6 intakes were not related to EALT-AC and EAST-AC values during patients' stay in the ICU.
On the 1st and 14th day in the ICU, urinary 4-PA excretion was determined to be 6.9 AE 5.2 and 9.4 AE 4.1 mmol=day, respectively. The values were above 3.0 mmol=day, which is Vitamin B6 intake of critically ill patients Y-C Huang et al considered to be associated with adequate vitamin B6 status (Leklem, 1990) . Unlike the results of plasma PLP and PL concentrations, urinary 4-PA concentration increased significantly after 14 days. The results of hematological measurements are also shown in Table 4 . The hemoglobin, albumin and TLC levels were on average below normal for patients on day 1. Patients showed no significant changes in hemoglobin, total protein, and albumin levels by day 14, but TLC increased significantly by day 14. Only plasma PL concentration correlated significantly negatively with TLC (r ¼ 70.365, P ¼ 0.0013) on day 1. Otherwise, no significant correlation was found between hematological measurements and vitamin B6 status indicators.
The severity of illness (APACHE II score), the length of ventilation dependency, the length of time in the ICU and hospital did not correlate with vitamin B6 intake or with any vitamin B6 status indicators (plasma PLP, PL, EALT-AC, EAST-AC, and urinary 4-PA; data not shown).
Discussion
To our knowledge, this is the first study to report vitamin B6 intake and status in critically ill patients. A variety of methods have been utilized to assess vitamin B6 status in this study including direct methods (plasma PLP and PL, urinary 4-PA), indirect methods (EALT, EAST and stimulation with PLP) and vitamin B6 intake.
Very little data on vitamin B6 consumption in hospitalized patients has been reported. Vir and Love (1978) reported that 18.6% of patients consumed less than 0.66 mg of vitamin B6 per day and only 21.6% of the patients had a vitamin B6 intake higher or equal to 1 mg. In an other study (Louw et al, 1992) , 25 subjects who underwent uncomplicated orthopedic surgery had an average of 1.7 and 1.6 mg vitamin B6 intake for men and women, respectively, 3 days after surgery. Elderly patients in the study of Powers et al (1993) consumed about 0.5 -4 mg=day pyridoxine. Mean vitamin B6 intake of our critically ill patients was certainly higher than the previous studies (Vir & Love, 1978; Louw et al, 1992; Powers et al, 1993) . This is probably because all our patients received nutritional support (EN, TPN or combined) in the ICU; patients often get micronutrient supplements to meet their requirements. However, it is worth noting that our patients had varied vitamin B6 intake, receiving anywhere from 0.4 to more than 92 mg vitamin B6 during the 14 day study (Table 3) . Physicians, nurses and=or dietitians should carefully identify the amount of nutrients patients receive in the ICU. Our study group had sufficient mean vitamin B6 intake. This might be the reason vitamin B6 intake did not have any effect on the APACHE II score, the length of ventilation dependency, and the length of time in the ICU and hospital.
It is not surprising to observe an adequate mean plasma PLP concentration ( > 20 nmol=l) in the critically ill since our patients had higher vitamin B6 intake than other studies (Vir & Love, 1978; Louw et al, 1992; Powers et al, 1993 ). An Vitamin B6 intake of critically ill patients Y-C Huang et al interesting finding was that mean plasma PLP concentration significantly decreased while vitamin B6 intake significantly increased by day 14. There was also no correlation between vitamin B6 intake and plasma PLP levels. In agreement with Powers et al (1993) , the lack of responsiveness of plasma PLP to vitamin B6 intake might be due to high doses of vitamin B6 supplementation in our critically ill patients during their ICU stay. Patients, therefore, might have sufficient PLP storage in the liver. However, hepatic PLP reserves might decrease as the critical clinical condition continues to exist in the critically ill. In addition, plasma PLP might redistribute from plasma to erythrocytes during the inflammatory state (Driskell, 1994) . It has been suggested that erythrocyte PLP is a better indicator of vitamin B6 status than plasma PLP level (Leklem, 1990; Lumeng et al, 1978) . Erythrocyte PLP status should be considered when assessing vitamin B6 status in the critically ill. Pyridoxal 5'-phosphate and PL are both bound to serum albumin, with the PLP binding more tightly, against rapid hydrolysis by alkaline phosphatase while being transported by the blood. Lower serum albumin levels in our critically ill patients may lead to the dephosphorylation of plasma PLP into PL (Merrill & Henderson, 1987) . Because dietary vitamin B6 and protein intake as well as plasma alkaline phosphatase activity may affect plasma PLP concentration, recent research has suggested that plasma PL may be useful as an indicator for vitamin B6 status (Leklem, 1990) . We did observe a significant amount of plasma PL concentration in our critically ill patients. Unfortunately, we could not compare plasma PL concentration of our patients with other studies because no studies reported plasma PL concentration in hospitalized patients.
Like plasma PLP, our critically ill patients had an adequate EALT-AC ( < 1.25) and EAST-AC ( < 1.8) level (Leklem, 1990) during their ICU stay. Hoorn et al, (1975) indicated that mean EAST-AC level was 1.58 AE 0.14 in 153 geriatric patients, which is considered to be adequate. Tébi et al (2000) reported that 590 diseased elderly people had an adequate mean EAST-AC level (1.75 AE 0.38). However, studies (Lui et al, 1985; Ribaya-Mercado et al, 1991) indicated that EAST-AC could be normal in the presence of chronic and marginal vitamin B6 deficiency. Therefore, EALT-AC rather than EAST-AC is a more sensitive indicator of vitamin B6 status (Brown et al, 1975; Leklem, 1990; Cochary et al, 1990) . On the other hand, no relationship was found between EALT-AC or EAST-AC levels with vitamin B6 intake or with any vitamin B6 status indicators in the present study. Kretsch et al (1995) indicated that the aminotransferases were more subject to individual variability; therefore, caution should be taken in using EALT or EAST values alone to interpret vitamin B6 status.
The major excretory metabolite of vitamin B6 in humans is urinary 4-PA, which is considered to be a short-term indicator of vitamin B6 status. Our critically ill patients not only had an adequate mean 4-PA concentration ( > 3.0 mmol=day; Leklem, 1990) , but it also increased proportionately to vitamin B6 intake. In agreement with previous reports (Brown et al, 1975; Leklem, 1990; Huang et al, 1998) , urinary 4-PA excretion changed rapidly in response to a change in vitamin B6 intake.
Vitamin B6 has a role in erythrocyte function and metabolism (Bottomley, 1983) . Pyridoxine-responsive anemias in humans have been reported (Horrigan & Harris, 1968) . Patients had low hemoglobin concentrations in our study; however, vitamin B6 status revealed no effect on hemoglobin concentration. This finding agrees with that of other studies (Ribaya-Mercado et al, 1991; Huang et al, 1998) . Patients had low hemoglobin concentrations which may be caused by other factors.
Conclusion
Critically ill patients received appropriate and aggressive nutritional support in the ICU; they had sufficient mean vitamin B6 intake and adequate vitamin B6 status. Therefore, the severity of illness and clinical outcomes (the length of ventilation dependency, and the length of time in the ICU and hospital) might not be affected by vitamin B6 intake and status indicators. However, we have noted that plasma PLP and PL concentrations significantly decreased while vitamin B6 intake significantly increased on day 14. Critical clinical conditions and complex metabolism in the critically ill may account for the reduction of plasma PLP and PL. Since vitamin B6 is required for normal nucleic acid and protein synthesis and for cellular multiplication, vitamin B6 deficiency causes profound effects on immune system function (Axlerod 1971; Talbott et al, 1987) . Dietary or supplemented vitamin B6 intake is suggested for hospitalized patients.
